Genmab AS (GMAB) — Cash Flow Reinvestment Rate
Genmab AS (GMAB) has a Cash Flow Reinvestment Rate of 5.56x as of December 2025, reinvesting $1.67 Billion (capex $12.99 Million plus investments $1.66 Billion) from operating cash flow of $300.34 Million. Check GMAB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genmab AS Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Genmab AS across 15 annual periods. Explore Genmab AS long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Genmab AS (2007–2025)
Year-by-year capital reinvestment analysis for Genmab AS. For live market cap and broader valuation context, see Genmab AS market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.40x | $1.66 Billion | $1.19 Billion | $37.03 Million | ▲ +7.9% |
| 2024 | 1.30x | $10.09 Billion | $7.77 Billion | $187.00 Million | ▲ +609.0% |
| 2023 | 0.18x | $1.35 Billion | $7.38 Billion | $376.00 Million | ▼ -76.7% |
| 2022 | 0.79x | $3.08 Billion | $3.91 Billion | $317.00 Million | ▲ +82.4% |
| 2021 | 0.43x | $961.00 Million | $2.23 Billion | $252.00 Million | ▲ +4.4% |
| 2020 | 0.41x | $2.66 Billion | $6.43 Billion | $307.00 Million | ▼ -73.8% |
| 2019 | 1.58x | $2.09 Billion | $1.33 Billion | $111.00 Million | ▼ -28.9% |
| 2018 | 2.22x | $2.25 Billion | $1.01 Billion | $477.37 Million | ▲ +367.0% |
| 2017 | 0.48x | $756.08 Million | $1.59 Billion | $88.51 Million | ▼ -85.1% |
| 2016 | 3.20x | $1.05 Billion | $327.72 Million | $33.11 Million | ▲ +629.7% |
| 2015 | 0.44x | $136.45 Million | $311.45 Million | $135.39 Million | ▼ -23.0% |
| 2014 | 0.57x | $75.44 Million | $132.67 Million | $75.44 Million | ▲ +348.2% |
| 2012 | 0.13x | $9.00 Million | $70.92 Million | $9.00 Million | ▲ +236.5% |
| 2010 | 0.04x | $10.11 Million | $268.17 Million | $10.11 Million | ▲ +48.5% |
| 2007 | 0.03x | $12.84 Million | $505.90 Million | $12.84 Million | — |